Health leaders have called for urgent global cooperation on COVID-19 vaccine supply and access, particularly in Africa where only 2% of total doses worldwide have been administered.

The longer vaccine inequity persists, the more the virus will keep circulating and changing, the longer the social and economic disruption will continue, and the higher the chances that more variants will emerge that render vaccines less effective.” 

Dr Tedros Adhanom Ghebreyesus, Director-General, WHO

International taskforce works with CEOs of vaccine manufacturers to accelerate access to COVID-19 vaccines.

COVAX expects target of 2 billion doses will be delayed until early 2022 due to wealthy countries buying up supply, export bans and other challenges.